Digital innovation in clinical trials: Strategic implications for drug and device development

Published on: 

In this panel discussion, industry experts Dr. Scott Gottlieb, Joel Haspel, and Shwen Gwee explore the effects and evolution of digital innovation, as well as the regulatory stance on the acceleration and adoption of digital tools in clinical trials.